Call for Abstract Submissions

The deadline for the submission of Abstracts is 12 July 2010. 

All attendees are invited to submit an Abstract to be considered for display at the 2010 Global TB Vaccine Conference.  Abstracts will be reviewed, in advance, for relevance to the conference subject matter by an Advisory Committee Panel.  Each Abstract should contain a Title,  Author name(s) with Affiliations and should be no greater in length than one page, single spaced, in size 11 font.

The primary focus of this conference will be the following disciplines:

Basic Research - New findings in molecular, immunological, and pathogenesis and epidemiologic research, vaccine delivery and adjuvants.

Applied Research - Vaccine products; assay development; biomarkers; and preclinical studies.

Clinical Studies on TB Vaccines - Vaccines in clinical studies; lessons learned from trials; immunization strategies; phase II and III studies; next generation vaccines.

Manufacturing, Regulation and Vaccine Access - Pilot facilities; industrial  development of TB vaccines; role of developing countries; IP issues and technology transfer; global regulation pathways; GMP assays.

Partnerships, Communication & Coordination - Role of major institutions and international organizations in TB vaccine development; coordinating new vaccine and new diagnostics studies; working in developing countries.

You will be notified via e-mail of acceptance of your Abstract for presentation as a poster at the meeting.  

Stipends are no longer available as a result of abstract submission.

If you are still interested in submitting an abstract for display at the conference, please submit directly to abstracts@tbvaccine2010.org